Europe, MEA & CIS Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Analysis Report By Component (Pumps, Oxygenators), By Modality, By Application, By Region And Segment Forecasts, 2024 - 2030

Market Size & Trends

The Europe, MEA & CIS extracorporeal membrane oxygenation machine marketsize was valued at USD 331.2 million in 2023 and is projected to grow at a CAGR of 4.6% from 2024 to 2030. The increasing prevalence of cardiopulmonary diseases, a rising geriatric population, and the growing adoption of extracorporeal membrane oxygenation (ECMO) in critical care settings are some of the key factors contributing to the market growth. In addition, technological advancements and supportive government initiatives are enhancing market dynamics. The increased awareness of ECMO benefits, particularly in organ transplantation and severe respiratory conditions, further propels its demand across healthcare facilities.

Extracorporeal membrane oxygenation (ECMO) is a life-support technique that temporarily takes over the functions of the heart and lungs for patients whose organs are failing. It involves pumping blood out of the body to an artificial lung, where it is oxygenated, and carbon dioxide is removed before returning it to the patient. ECMO is often used in critical care settings for severe respiratory or cardiac failure, providing vital support while underlying conditions are treated or until recovery occurs.

In addition, ECMO may be utilized to assist individuals who have conditions that cause heart or lung failure and for those who are on hold for or recovering from a heart or lung transplant. Moreover, the driving factors for the ECMO machine market involve the increasing prevalence of cardiopulmonary and respiratory diseases and a rising number of patients with Chronic Obstructive Pulmonary Disease (COPD).

Furthermore, the ECMO machine works for children's hearts and lungs while they are recovering from a life-threatening condition. Congenital or acquired heart conditions, with myocarditis or congenital heart disease, need pediatrics to be placed on ECMO life support. ECMO helps with recovery after cardiac surgery until his or her heart and lungs function properly.

The growth of this market is also driven by the rising geriatric population, increasing incidence of severe complications of cardiac diseases, and assistance of government regulations. With strategic collaborations & investments by the key companies, and initiatives, the development of the regional healthcare sector also facilitates the demand for extracorporeal membrane oxygenation machines. 

Component Insights

The oxygenators dominated the market and accounted for the largest revenue share of 31.1% in 2023. They eliminate carbon dioxide and supply oxygenated blood to the patient’s body, which helps the heart and lungs recover. The advantages of using ECMO oxygenators include support in severe respiratory disorders or cardiac failure, minimizing the strain on the patient’s organs, and improving survival rates in complex situations.

Pumps are expected to grow at a CAGR of 5.1% over the forecast period. These pumps are utilized in ECMO techniques as per requirements. These devices assist in pumping blood from a patient to artificial lungs, then restoring the blood to the patient after oxygenation. The high use of pumps in ECMO treatments, with the accessibility of various types such as roller, impeller, and centrifugal, is driving the market growth. Furthermore, pumps are crucial in medical settings that have evolved many processes by improving efficiency and reliability. Pumps are essential devices for ECMO machines, infusion pumps, and dialysis machines, making precise and controlled operation of fluid supply and medications. 

Modality Insights

The veno-arterial led the market and accounted for the largest revenue share of 40.6% in 2023 attributed to its essential help for respiratory or cardiac failure patients, making it a required intervention in disorders with complications. The veno-arterial (VA) modality is particularly vital as it supports both the heart and lungs by diverting blood from a vein, oxygenating it outside the body, and then returning it to an artery. This process ensures that oxygenated blood is delivered to the internal body parts, maintaining functions while the heart and lungs recover. It is often employed in cases of cardiogenic shock, in which the heart is not able to pump enough blood.

Arterio-venous is expected to grow at a CAGR of 4.5% over the forecast period. The arterio-venous (AV) modality in extracorporeal membrane oxygenation (ECMO) machines plays an important role in the market due to its unique advantages such as its highly effective and better medical assessment linked with the technology. The AV ECMO system circulates blood from the patient’s arteries and veins to the ECMO machine, where it is oxygenated and then returned to the body. This modality is particularly effective in providing both gas exchange and hemodynamic support, making it right for patients with complex cardiac and respiratory disorders.

Application Insights

Respiratory applications dominated the market and accounted for the largest revenue share of 44.2% in 2023 driven by the rising aging population, treating respiratory disorders, such as respiratory failure, acute respiratory distress syndrome (ARDS), hypercapnia respiratory failure (HRF), pulmonary hypertension, respiratory distress syndrome, and severe pneumonia, influencing its wide range of applications. Moreover, ECMOs aid as artificial lungs, with a vital role in supporting the proper function of the pulmonary.

ECPR is expected to grow at a CAGR of 5.1% over the forecast period. The growth factors of extracorporeal cardiopulmonary resuscitation (ECPR) provides significant benefits in managing cardiac arrest. Its ability to increase blood flow and oxygen delivery during cardiac arrest aids in lowering irreversible end-organ injury and hypoxic brain injury. Moreover, it improves neurologically favorable survival for patients with severe cardiac arrest occurring by shockable presenting rhythms.

Regional Insights

Europe extracorporeal membrane oxygenation machine market dominated the global market and accounted for the largest revenue share of 26.8% in 2023. This growth is attributed to the increasing prevalence of respiratory and cardiovascular diseases, particularly among the aging population. Technological advancements in ECMO devices enhance their adoption in hospitals while rising health awareness and access to healthcare services further contribute to market expansion. Furthermore, government initiatives aimed at improving critical care infrastructure and funding for innovative medical technologies play a significant role in driving demand for ECMO machines across the region.

The extracorporeal membrane oxygenation machine market in Russia led the European market and accounted for the largest revenue share of 13.1% in 2023. This growth is driven by the rising incidence of respiratory and cardiovascular diseases, significantly increases the demand for ECMO devices. In addition, advancements in technology enhance the efficacy and safety of these machines, promoting their adoption in healthcare facilities. Furthermore, increased awareness of ECMO's benefits and improvements in healthcare infrastructure and access to medical services further support market expansion. However, challenges such as high costs and regulatory hurdles may impact growth potential in the region.

Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market Trends

Middle East & Africa extracorporeal membrane oxygenation machine market is expected to grow at a CAGR of 4.7% over the forecast period. This growth is driven by the rising prevalence of respiratory and cardiovascular diseases, especially in developing economies. In addition, increased government expenditure on healthcare infrastructure and the adoption of advanced medical technologies in the region are also contributing to the market's expansion. The growing geriatric population base and rising personal disposable incomes in countries such as Saudi Arabia, UAE, and South Africa are further fueling the demand for extracorporeal membrane oxygenation machines. Furthermore, the presence of key players in the region and their focus on geographic expansions and technological innovations are expected to drive the market forward in the coming years.

The extracorporeal membrane oxygenation machine market in Saudi Arabia is expected to grow significantly over the forecast years owing to the rising incidence of chronic obstructive pulmonary disease (COPD) and the risk associated with myocardial infarction. Furthermore, healthcare reforms are also expected to play a crucial role in the expansion of the ECMO market.

Commonwealth of Independent States (CIS) Extracorporeal Membrane Oxygenation Machine Market Trends

The growth of the Commonwealth of Independent States (CIS) extracorporeal membrane oxygenation (ECMO) machine market is driven by the rising prevalence of cardiovascular and respiratory diseases, which necessitate advanced life support solutions. Increased healthcare investments and the establishment of more ECMO centers enhance accessibility and treatment options. Furthermore, the aging population and growing awareness of ECMO's benefits contribute to market expansion. Technological advancements and improved healthcare infrastructure further support the adoption of these critical medical devices across the region.

Key Europe, MEA & CIS Extracorporeal Membrane Oxygenation Machine Company Insights

Some of the key companies in the Europe, MEA, and CIS extracorporeal membrane oxygenation machine market include Medtronic, Microport Scientific Corporation, Terumo Cardiovascular Systems Corporation, Medos Austria, Nipro Medical Corporation, and LivaNova PLC. These companies are in the market and are focusing on continuous development and innovation to gain a competitive edge in the industry.

• Medtronic is a healthcare technology company that specializes in the development and marketing of medical devices and solutions to address various health complications. The company’s product range includes treatments for conditions affecting the heart, such as valve disorders and heart failure, as well as diseases related to the coronary and peripheral vascular systems, neurological issues, and musculoskeletal disorders.

• Microport Scientific Corporation is a global medical technology firm that designs and manufactures a wide array of medical devices. The company’s expertise spans multiple disciplines, including cardiology, interventional radiology, orthopedics, electrophysiology, and surgical management, catering to diverse healthcare needs across international markets.

Recent Developments

• In June 2024, Getinge and Aragen Bioscience formed a strategic partnership focused on enhancing biopharmaceutical production through the validation of Getinge's SUPR Single-Use Bioreactors. This collaboration aims to address the need for larger-scale production capabilities, enabling Aragen to efficiently scale up from smaller bioreactors to 50 L and 250 L single-use systems. The partnership is designed to streamline processes, reduce contamination risks, and support compliance with Good Manufacturing Practices (GMP), ultimately benefiting clinical trial preparations and biopharmaceutical manufacturing.

• In July 2024, Nipro Medical Corporation announced the opening of its first North American manufacturing facility in Greenville, North Carolina, marking a significant expansion for the company. This facility aims to produce advanced medical devices, particularly for patients with diabetes and chronic kidney disease. The new site is expected to create numerous jobs and reduce transportation costs, contributing to a more sustainable supply chain while reinforcing Nipro's commitment to environmental stewardship and innovation in healthcare.

Europe, MEA & CIS Extracorporeal Membrane Oxygenation Machine Market Report Scope

Europe, MEA & CIS Extracorporeal Membrane Oxygenation Machine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the Europe, MEA, and CIS extracorporeal membrane oxygenation machine market report based on component, modality, application, and region. 

• Component Outlook (Revenue, USD Million, 2018 - 2030)

  • Pumps

  • Oxygenators

  • Controllers

  • Cannula

  • Accessories

• Modality Outlook (Revenue, USD Million, 2018 - 2030)

  • Veno-Arterial

  • Veno-Venous

  • Arterio-Venous

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Respiratory

  • Cardiac

  • ECPR

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • Europe

    • Czech Republic

    • Russia

    • Estonia

    • Turkey

    • ROE

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Bahrain

    • Kuwait

    • Qatar

    • Oman

    • Israel

  • Commonwealth and Independent States (CIS)

    • Azerbaijan

    • Armenia

    • Belarus

    • Uzbekistan

    • Kazakhstan